63 related articles for article (PubMed ID: 21215541)
1. Comparison of qualitative and quantitative approach to prostate MR spectroscopy in peripheral zone cancer detection.
Klijn S; De Visschere PJ; De Meerleer GO; Villeirs GM
Eur J Radiol; 2012 Mar; 81(3):411-6. PubMed ID: 21215541
[TBL] [Abstract][Full Text] [Related]
2. A qualitative approach to combined magnetic resonance imaging and spectroscopy in the diagnosis of prostate cancer.
Villeirs GM; Oosterlinck W; Vanherreweghe E; De Meerleer GO
Eur J Radiol; 2010 Feb; 73(2):352-6. PubMed ID: 19084363
[TBL] [Abstract][Full Text] [Related]
3. Standardized threshold approach using three-dimensional proton magnetic resonance spectroscopic imaging in prostate cancer localization of the entire prostate.
Fütterer JJ; Scheenen TW; Heijmink SW; Huisman HJ; Hulsbergen-Van de Kaa CA; Witjes JA; Heerschap A; Barentsz JO
Invest Radiol; 2007 Feb; 42(2):116-22. PubMed ID: 17220729
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined.
Chen M; Dang HD; Wang JY; Zhou C; Li SY; Wang WC; Zhao WF; Yang ZH; Zhong CY; Li GZ
Acta Radiol; 2008 Jun; 49(5):602-10. PubMed ID: 18568549
[TBL] [Abstract][Full Text] [Related]
5. Value of endorectal MRI and MRS in patients with elevated prostate-specific antigen levels and previous negative biopsies to localize peripheral zone tumours.
Cirillo S; Petracchini M; Della Monica P; Gallo T; Tartaglia V; Vestita E; Ferrando U; Regge D
Clin Radiol; 2008 Aug; 63(8):871-9. PubMed ID: 18625351
[TBL] [Abstract][Full Text] [Related]
6. Peripheral zone prostate cancer. Pre-treatment evaluation with MR and 3D ¹H MR spectroscopic imaging: correlation with pathologic findings.
Giusti S; Caramella D; Fruzzetti E; Lazzereschi M; Tognetti A; Bartolozzi C
Abdom Imaging; 2010 Dec; 35(6):757-63. PubMed ID: 19756851
[TBL] [Abstract][Full Text] [Related]
7. The potential role of prebiopsy magnetic resonance imaging combined with prostate-specific antigen density in the detection of prostate cancer.
Kubota Y; Kamei S; Nakano M; Ehara H; Deguchi T; Tanaka O
Int J Urol; 2008 Apr; 15(4):322-6; discussion 327. PubMed ID: 18380820
[TBL] [Abstract][Full Text] [Related]
8. Computerized characterization of prostate cancer by fractal analysis in MR images.
Lv D; Guo X; Wang X; Zhang J; Fang J
J Magn Reson Imaging; 2009 Jul; 30(1):161-8. PubMed ID: 19557732
[TBL] [Abstract][Full Text] [Related]
9. Apparent diffusion coefficient: prostate cancer versus noncancerous tissue according to anatomical region.
Kim JH; Kim JK; Park BW; Kim N; Cho KS
J Magn Reson Imaging; 2008 Nov; 28(5):1173-9. PubMed ID: 18837000
[TBL] [Abstract][Full Text] [Related]
10. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
11. Underestimation of Gleason score at prostate biopsy reflects sampling error in lower volume tumours.
Corcoran NM; Hovens CM; Hong MK; Pedersen J; Casey RG; Connolly S; Peters J; Harewood L; Gleave ME; Goldenberg SL; Costello AJ
BJU Int; 2012 Mar; 109(5):660-4. PubMed ID: 21895937
[TBL] [Abstract][Full Text] [Related]
12. [Value of 3D 1H-MRS with body coil at 3T in the differential diagnosis of the prostate cancer].
Wang F; Dai YP; Sun XZ; Guo Y; Chen YQ; Mao LJ; Wang DH; Deng CH
Zhonghua Nan Ke Xue; 2009 May; 15(5):431-6. PubMed ID: 19514556
[TBL] [Abstract][Full Text] [Related]
13. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
[TBL] [Abstract][Full Text] [Related]
14. MR spectroscopy of prostate cancer. Initial clinical experience.
Squillaci E; Manenti G; Mancino S; Carlani M; Di Roma M; Colangelo V; Simonetti G
J Exp Clin Cancer Res; 2005 Dec; 24(4):523-30. PubMed ID: 16471314
[TBL] [Abstract][Full Text] [Related]
15. Automated detection of prostatic adenocarcinoma from high-resolution ex vivo MRI.
Madabhushi A; Feldman MD; Metaxas DN; Tomaszeweski J; Chute D
IEEE Trans Med Imaging; 2005 Dec; 24(12):1611-25. PubMed ID: 16350920
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of normal prostate tissue, chronic prostatitis, and prostate cancer by quantitative perfusion analysis using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence.
Franiel T; Lüdemann L; Rudolph B; Rehbein H; Staack A; Taupitz M; Prochnow D; Beyersdorff D
Invest Radiol; 2008 Jul; 43(7):481-7. PubMed ID: 18580330
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy of proton magnetic resonance spectroscopy (1H-MRS) in the diagnosis of localized prostate cancer.
Saito K; Kaminaga T; Muto S; Ide H; Nishio K; Kamiyama Y; Okada H; Terado Y; Furui S; Horie S
Anticancer Res; 2008; 28(3B):1899-904. PubMed ID: 18630478
[TBL] [Abstract][Full Text] [Related]
18. Prediction of prostate-specific antigen recurrence in men with long-term follow-up postprostatectomy using quantitative nuclear morphometry.
Veltri RW; Miller MC; Isharwal S; Marlow C; Makarov DV; Partin AW
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):102-10. PubMed ID: 18199716
[TBL] [Abstract][Full Text] [Related]
19. Effect of finasteride on the sensitivity of PSA for detecting prostate cancer.
Thompson IM; Chi C; Ankerst DP; Goodman PJ; Tangen CM; Lippman SM; Lucia MS; Parnes HL; Coltman CA
J Natl Cancer Inst; 2006 Aug; 98(16):1128-33. PubMed ID: 16912265
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of semi-quantitative dynamic contrast-enhanced MRI parameters for prostate cancer in correlation to whole-mount histopathology.
Isebaert S; De Keyzer F; Haustermans K; Lerut E; Roskams T; Roebben I; Van Poppel H; Joniau S; Oyen R
Eur J Radiol; 2012 Mar; 81(3):e217-22. PubMed ID: 21349667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]